Document is current
Any future updates will be listed below
-
Authors
Salles Rosa Neto, Nilton https://orcid.org/0000-0001-8457-5132
Bento, Judith Campos de Barros https://orcid.org/0000-0002-3355-6895
Takayama, Liliam https://orcid.org/0000-0001-5845-4230
Caparbo, Valéria de Falco https://orcid.org/0000-0002-6606-8628
Pereira, Rosa Maria Rodrigues https://orcid.org/0000-0002-3723-5028
Domiciano, Diogo Souza https://orcid.org/0000-0001-7991-0231
-
Funding
Funding for this research was provided by:
Sociedade Brasileira de Reumatologia
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 3 April 2025
First Online: 10 June 2025
Declarations
:
: This work was approved by Faculdade de Medicina da Universidade de São Paulo Ethics Review Board under number 1.464.841 on March 24th, 2016. All patients read and signed informed consent to participate. The procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 1983.
: Written informed consent for publication of their clinical details was obtained from the patients.
: Nilton Salles Rosa Neto reports financial support provided by Sociedade Brasileira de Reumatologia. Nilton Salles Rosa Neto reports a relationship with Takeda Pharmaceutical Company Limited that includes: speaking and lecture fees. Nilton Salles Rosa Neto reports a relationship with Pint Pharma that includes: speaking and lecture fees. Nilton Salles Rosa Neto reports a relationship with Recordati Rare Diseases that includes: speaking and lecture fees. Nilton Salles Rosa Neto reports a relationship with Sanofi that includes: speaking and lecture fees. JCBB declares that spouse received speaker´s fees from Takeda Pharmaceuticals, Pint Pharma, Recordati Rare Diseases and Sanofi. LT, VFC, RMRP and DSD declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
